LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.17783
6.06 84.90 1 365 0.0027 -0.8787
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
6.06 84.90 920 365 2.5174 2.1005
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
7.77 84.90 14 411 0.0340 -0.5470
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
7.77 84.90 728 411 1.7703 1.5704
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
7.77 84.90 1 411 0.0024 -0.8579
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
7.77 84.90 966 411 2.3490 1.9105
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
9.47 84.90 10 447 0.0224 -0.5902
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
9.47 84.90 730 447 1.6315 1.4530
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
9.47 84.90 1 447 0.0022 -0.8431
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
9.47 84.90 976 447 2.1814 1.7688
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
11.18 84.90 17 492 0.0345 -0.4696
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
11.18 84.90 744 492 1.5111 1.3536
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
11.18 84.90 2 492 0.0041 -0.7719
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
11.18 84.90 1055 492 2.1428 1.7011
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
12.88 84.90 34 531 0.0640 -0.2925
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
12.88 84.90 832 531 1.5669 1.3701
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
12.88 84.90 2 531 0.0038 -0.7576
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
12.88 84.90 1148 531 2.1620 1.6769
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
14.58 84.90 35 663 0.0528 -0.2583
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
14.58 84.90 818 663 1.2330 1.1464
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
14.58 84.90 5 663 0.0075 -0.6151
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
14.58 84.90 1125 663 1.6958 1.3898
MN20160318_Q02
I16
MCF 10A-H2B-mCherry Neratinib
0.17783
16.29 84.90 37 766 0.0482 -0.2302
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
16.29 84.90 800 766 1.0432 1.0268
MN20160318_Q02
F22
MCF 10A-H2B-mCherry Neratinib
0.17783
16.29 84.90 9 766 0.0117 -0.5068
MN20160318_Q02
I16